Pulse Biosciences, Inc. (PLSE) — Stock Score Summary

Pulse Biosciences, Inc. (PLSE) has a MoatMap StockRank of 41/100 based on Quality (26/100), Value (32/100), and Momentum (69/100) factor scores. The current signal is HOLD. Pulse Biosciences is an early-stage medical device company with highly speculative cash flows and no established market moat. It fails the Warren Buffett margin of safety test and does not align with any of our high-conviction macro themes.

Pulse Biosciences is a novel medical technology company pioneering the development of its proprietary Nano-Pulse Stimulation (NPS) technology for cellular tissue clearance. The company's CellFX system delivers nanosecond electrical pulses to non-thermally clear targeted cells while sparing surrounding non-cellular tissue. Its competitive moat is anchored by a robust intellectual property portfolio and a unique, high-margin consumable business model in dermatology and other surgical applications.

Key Financial Metrics

Price$24.99
Market Cap$1.7B
P/E (Forward)-24.72
Price/Book22.66
Return on Equity-80.7%
Return on Invested Capital-88.8%
Debt/Equity10.79
Gross Margin-21.0%
Operating Margin-4775.6%
Free Cash Flow$-29M

Pulse Biosciences, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Pulse Biosciences, Inc.’s (PLSE) StockRank?
MoatMap’s StockRank for Pulse Biosciences, Inc. (PLSE) is 41/100, with a Hold signal. It is a composite of Quality (26), Value (32), and Momentum (69) factor ranks across MoatMap’s 19,000+ stock universe.
Does Pulse Biosciences, Inc. have an economic moat?
Pulse Biosciences, Inc. (PLSE) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Pulse Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Pulse Biosciences, Inc. (PLSE) is Hold, based on a StockRank of 41/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Pulse Biosciences, Inc. in?
Pulse Biosciences, Inc. (PLSE) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).
Browse all ranked stocksPLSE deep dive reportAI ChampionsHow we score stocksSense-check another stock